KAŇOVSKÝ, Jan, Tomáš NOVOTNÝ, Jitka KADLECOVÁ and Renata GAILLYOVÁ. A new homozygous mutation of the KCNQ1 gene associated with both Romano-Ward and incomplete Jervell Lange-Nielsen syndromes in two sisters. Heart Rhythm. USA: Elsevier Science, 2010, vol. 7, No 4, p. 531-533. ISSN 1547-5271. Available from: https://dx.doi.org/10.1016/j.hrthm.2009.11.034.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A new homozygous mutation of the KCNQ1 gene associated with both Romano-Ward and incomplete Jervell Lange-Nielsen syndromes in two sisters
Authors KAŇOVSKÝ, Jan (203 Czech Republic, guarantor, belonging to the institution), Tomáš NOVOTNÝ (203 Czech Republic, belonging to the institution), Jitka KADLECOVÁ (203 Czech Republic, belonging to the institution) and Renata GAILLYOVÁ (203 Czech Republic, belonging to the institution).
Edition Heart Rhythm, USA, Elsevier Science, 2010, 1547-5271.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.246
RIV identification code RIV/00216224:14110/10:00064822
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.hrthm.2009.11.034
UT WoS 000276190000018
Keywords in English KCNQ1; Jervel Lange-Nielsen syndrome; Romano-Ward syndrome
Tags International impact
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 5/10/2012 09:49.
Abstract
The mutations in the KCNQ1 gene (GenBank accession no. AF000571) encoding the subunit of the KCNQ1 channel can cause 2 different diseases: Romano-Ward syndrome (RWS), traditionally described as a combination of repeated syncope episodes and a prolonged QT interval, and the less frequent Jervell and Lange-Nielsen syndrome (JLNS), also associated (except for the abovementioned symptoms) with congenital bilateral deafness.1 The first one is usually associated with the heterozygous gene mutation, the latter one with the homozygous mutation. The disease prevalence is estimated at close to 1 in 2,500 live births, and JLNS has been reported to affect about 3 in 1 million individuals, which represents less than 1% of all long-QT syndrome (LQTS) patients.
Links
NR9340, research and development projectName: Výskyt polymorfizmů genů pro iontové kanály myokardu ve vztahu k náhlé srdeční smrti u pacientů se strukturálním onemocněním srdce
Investor: Ministry of Health of the CR
PrintDisplayed: 1/5/2024 07:15